source
- FDA clears Bristol Myers' Zenbexus, first drug of a new class for advanced multiple myelomaThe FDA announced approval of an oral therapy from Bristol Myers Squibb for patients with advanced multiple myeloma. The drug, iberdomide, will be marketed as Zenbexus and is intended to be used t…
- STAT+: PBMs agree to display TrumpRx drug pricesBristol's Zenbexus wins accelerated approval, Novartis wins UK patent fight over Entresto, and more biotech news from The ReadoutSTAT · 59m ago↗ source